PMC:6730630 / 24720-25155 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/6730630","sourcedb":"PMC","sourceid":"6730630","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6730630","text":"Suboptimal uptitration of secondary prevention medication following acute MI is not a problem unique to NHS Greater Glasgow and Clyde. Evidence from the UK and international healthcare systems highlights the need for further work.20–27 The optimisation of ACEI (or ARB) and beta-blocker seen in this programme is superior to that described in previous studies and, therefore, some of the learning may be applicable to other areas.25–27","tracks":[{"project":"2_test","denotations":[{"id":"31544164-27747827-15233855","span":{"begin":433,"end":435},"obj":"27747827"}],"attributes":[{"subj":"31544164-27747827-15233855","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"2_test","color":"#b3ec93","default":true}]}]}}